SEC Form 4 · accession 0001140361-15-043444
NEVRO CORP · NVRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andre Walker
Officer — Senior VP,Research&Development
Period of report
Nov 30, 2015
Accepted (ET)
Dec 2, 2015 · 5:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001444380
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 30, 2015 | M | 6,000 | $0.96 | A | 6,470 | D | |
| Common Stock | Nov 30, 2015 | S | 1,000 | $56.00 | D | 5,470 | D | |
| Common Stock | Nov 30, 2015 | S | 1,000 | $57.00 | D | 4,470 | D | |
| Common Stock | Nov 30, 2015 | S | 1,000 | $58.00 | D | 3,470 | D | |
| Common Stock | Nov 30, 2015 | S | 1,000 | $59.00 | D | 2,470 | D | |
| Common Stock | Nov 30, 2015 | S | 1,000 | $60.00 | D | 1,470 | D | |
| Common Stock | Nov 30, 2015 | S | 1,000 | $61.00 | D | 470 | D | |
| Common Stock | Dec 1, 2015 | M | 2,000 | $0.96 | A | 2,470 | D | |
| Common Stock | Dec 1, 2015 | S | 1,000 | $62.00 | D | 1,470 | D | |
| Common Stock | Dec 1, 2015 | S | 1,000 | $63.00 | D | 470 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $0.96 | Nov 30, 2015 | M | 6,000 | D | — | Dec 12, 2017 | Common Stock | 6,000 | 3,302 | D |
| Stock Option (right to buy)F2 | $0.96 | Dec 1, 2015 | M | 2,000 | D | — | Dec 12, 2017 | Common Stock | 2,000 | 1,302 | D |
| Stock Option (right to buy)F3 | $63.23 | Dec 1, 2015 | A | 14,000 | A | — | Nov 30, 2025 | Common Stock | 14,000 | 14,000 | D |
Explanation of responses
- F1The sales were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- F2100% of the shares subject to the option are fully vested and exercisable.
- F31/48th of the shares subject to the option vest on each monthly anniversary measured from November 5, 2015 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.